Efficacy of Autologous Bone Marrow–Derived Stem Cell Transplantation in Patients With Type 2 Diabetes MellitusAnil Bhansali, Santosh Ramakrishnan, Sanjay Kumar Bhadada et al.|Stem Cells and Development|2009Cited by 131
Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH/IGF‐1 axisKarthik Narayanan, R. K. Marwaha, Neelam Varma et al.|Pediatric Blood & Cancer|2013Cited by 85
Acquired neuro-secretory defect in growth hormone secretion due to Imatinib mesylate and the efficacy of growth hormone therapy in children with chronic myeloid leukemiaRama Walia, Deepak Bansal, Neelam Varma et al.|Pediatric Hematology and Oncology|2019Cited by 19
Efficacy and safety of autologous bone marrow derived hematopoietic stem cell transplantation in patients with type 2 DM: A 15 months follow-up studyAnil Bhansali, Niranjan Khandelwal, Sandeep Grover et al.|Indian Journal of Endocrinology and Metabolism|2014Cited by 16